Validation and comparison of quality‐of‐life measures for topical 5‐fluorouracil treatment: results from a randomized controlled trial

Summary Background Topical 5‐fluorouracil (5‐FU) is commonly used for high‐risk patients with keratinocyte carcinoma (KC). Skindex and Skin Cancer Index (SCI) are validated instruments to measure quality of life (QoL) of patients with KC and those who have had surgical treatment of KCs. Aim To valid...

Full description

Bibliographic Details

Published in:	Clinical and experimental dermatology Vol. 42; no. 5; pp. 488 - 495
Main Authors:	Pomerantz, H., Chren, M.‐M., Lew, R., Weinstock, M. A., Hogan, D, Eilers, D., Swetter, S., Chen, S. C., Jacob, S., Warshaw, E. M., Stricklin, G., Dellavalle, R. P., Konnikov, N., Werth, V., Sidhu‐Malik, N., Keri, J., Swan, J. W., Nord, K., Pollack, B., Kempiak, S., High, W., Fett, N., Hall, R.l P., Alonso‐Llamazares, J.r, Rodriguez, G.
Format:	Journal Article
Language:	English
Published:	England Oxford University Press 01-07-2017
Subjects:	5-Fluorouracil Administration, Cutaneous Analysis of Variance Cream Female Fluorouracil - therapeutic use Humans Male Quality of Life Risk groups Skin cancer Skin Neoplasms - prevention & control Surveys and Questionnaires Toxicity Veterans
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!